Email this article PROBLEMS OF FINAL PHASE POLIOMYELITIS ERADICATION PROGRAMME
- Authors: Chernyavskaya O.P.1, Briko N.I.1
-
Affiliations:
- Sechenov First Moscow State Medical University
- Issue: Vol 94, No 4 (2017)
- Pages: 75-81
- Section: TOPICAL ISSUES IN SCIENCE
- URL: https://microbiol.crie.ru/jour/article/view/182
- DOI: https://doi.org/10.36233/0372-9311-2017-4-75-81
- ID: 182
Cite item
Full Text
Abstract
Never before has the world community were not so close to the goal - poliomyelitis eradication. In 2016, the world recorded only 37 cases in the three endemic countries: Pakistan, Afghanistan and Nigeria. Despite the great progress in the final stages of poliomyelitis eradication have problems: the emergence and circulation of vaccine-derived poliovirus and related diseases, vaccine-associated paralytic poliomyelitis, social and political factors affecting of vaccination.
About the authors
O. P. Chernyavskaya
Sechenov First Moscow State Medical University
Author for correspondence.
Russian Federation
N. I. Briko
Sechenov First Moscow State Medical UniversityRussian Federation
References
- Доклад секретариата «Полиомиелит». Исполнительный комитет ВОЗ 140 сессия п.7.3. http://apps.who.int/gb/ebwha/pdf_files/EB140/B140_13-ru.pdf.
- Иванова О.Е., Еремеева Т.П., Морозова Н.С. и др. Вакциноассоциированный паралитический полиомиелит в Российской Федерации в период изменения схемы вакцинации (2006-2013 гг.). Вопросы вирусологии. 2016, 61 (1): 9-15.
- Иванова О.Е., Сейбиль В.Б., Липская ЕЮ. и др. Вирусологическое и серологическое исследование вспышек полиомиелита в Чеченской Республике в 1995 г. Журн. микро-биол. 1996, 3: 11-13.
- Онищенко Г. Г., Ежлова Е.Б., Мельникова А.А. и др. Полиомиелит в Таджикистане. Защита территории России от заноса и распространения дикого вируса полиомиелита. Журн. микробиол. 2011, 2: 12-22.
- Онищенко, Г.Г., Дроздов С.Г. и др. Проблемы ликвидации полиомиелита. Санкт-Петербург, 2008.
- Стратегический план ликвидации полиомиелита и осуществления завершающего этапа в 2013-2018 гг. http://polioeradication.org.
- Alexander L.N., Seward J.F., Santibanez Т.А. et al. Vaccine policy changes and epidemiology of poliomyelitis in the United States. JAMA. 2004, 292: 1696-1701.
- Centers for Disease Control and Prevention. Prolonged poliovirus excretion in an immunode-ficient person with vaccine-associated paralytic poliomyelitis. MMWR. 1997, 46: 641-643.
- Garon J., Patel M. The polio endgame: rationale behind the change in immunization. ADC Online First, published on January 17, 2017 as 10.1136/archdischi!d-2016-311171. http://adc. bmj.com/Downloaded from on January 18, 2017.
- Glynis Dunn, Dimitra Klapsa, Thomas Wilton et al. Twenty-Eight years of poliovirus replication in an immunodeflcient individual: Impact on the global polio eradication Initiative, Published: August 27, 2015, http://dx.doi.org/10.1371/journal.ppat. 1005114/.
- Henderson D.A., Witte J.J. Morris L.A., Langmuir D. Paralytic disease associated with oral polio vaccines, J. American Medical Association. 1964. 190:41-48.
- Kew O.M., Morris Glasgow V, Landaverde M. et al. Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science. 2002, 296: 356-359.
- Kew O.M., Sutter R.W., Nottay B. et al. Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeflcient patient. J. Clinical Microbiology 1998, 36: 2893-2899.
- Minor P Characteristics of poliovirus strains from longterm excretors with primary immunodeficiencies. Developments in Biologicals. 2001, 105: 75-80.
- Nkowane B.M., Wassilak S.G.F., Orenstein W.A. Vaccine-associated paralytic poliomyelitis. United States 1973 through 1984. J. Amer. Med. Assoc. 1987, 257: 1335-1340.
- Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep, 1997, 46 (RR-3): 1-25.
Supplementary files
